Vicarious Surgical Inc. (RBOT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Vicarious Surgical Inc.

    NYSE: RBOT · Real-Time Price · USD
    5.67
    -0.04 (-0.70%)
    At close: Sep 05, 2025, 3:57 PM
    5.69
    0.35%
    After-hours: Sep 05, 2025, 06:42 PM EDT

    Vicarious Surgical Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 2.11M 1.85M 1.94M 316K
    Gross Profit
    		 -2.11M -1.85M -1.94M -316K
    Operating Income
    		 -66.56M -80.67M -80.08M -38.22M
    Interest Income
    		 3.29M 4.43M 1.44M 20K
    Pretax Income
    		 -63.22M -71.07M 5.16M -35.21M
    Net Income
    		 -63.22M -71.07M 5.16M -35.21M
    Selling & General & Admin
    		 26.4M 33.09M 36.18M 16.16M
    Research & Development
    		 40.16M 47.58M 43.9M 22.1M
    Other Expenses
    		 -2.11M -1.85M n/a -41K
    Operating Expenses
    		 64.45M 78.81M 80.08M 38.22M
    Interest Expense
    		 n/a 25K 200K 89K
    Selling & Marketing Expenses
    		 4.53M 6.23M 6.46M 2.96M
    Cost & Expenses
    		 66.56M 80.67M 80.08M 38.22M
    Income Tax Expense
    		 n/a n/a n/a -227K
    Shares Outstanding (Basic)
    		 5.89M 4.83M 4.29M 3.22M
    Shares Outstanding (Diluted)
    		 5.89M 4.87M 4.25M 3.22M
    EPS (Basic)
    		 -10.72 -14.7 1.27 -10.92
    EPS (Diluted)
    		 -10.72 -14.6 1.21 -10.92
    EBITDA
    		 -61.12M -69.19M -78.97M -34.8M
    EBIT
    		 -63.22M -71.05M 5.36M -35.12M
    Depreciation & Amortization
    		 2.11M 1.85M 1.11M 316K

    Add to Watchlist